Hims Shares Notch Record Week as Novo Pact Spurs Optimism
Hims & Hers Health Inc. shares posted their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company’s future in weight-loss drugs.
The San Francisco-based company’s stock climbed about 57% this week, rallying in four of the past five trading sessions.